{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:53:11Z","timestamp":1760028791039},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,11,30]],"date-time":"2008-11-30T00:00:00Z","timestamp":1228003200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1007\/s00108-008-2194-9","type":"journal-article","created":{"date-parts":[[2008,11,28]],"date-time":"2008-11-28T04:33:53Z","timestamp":1227846833000},"page":"7-16","source":"Crossref","is-referenced-by-count":8,"title":["Epidemiologie und \u00c4tiologie der therapieresistenten Hypertonie"],"prefix":"10.1007","volume":"50","author":[{"given":"C.","family":"Schirpenbach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Reincke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,30]]},"reference":[{"key":"2194_CR1","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","volume":"288","author":"ALLHAT","year":"2002","unstructured":"ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial. (ALLHAT). JAMA 288: 2981\u20132997","journal-title":"JAMA"},{"key":"2194_CR2","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0895-7061(01)02193-8","volume":"14","author":"Brown","year":"2001","unstructured":"Brown M, Buddle M, Martin A (2001) Is resistant hypertension really resistant? Am J Hypertens 14: 1263\u20131269","journal-title":"Am J Hypertens"},{"key":"2194_CR3","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1161\/CIRCULATIONAHA.108.189141","volume":"117","author":"Calhoun","year":"2008","unstructured":"Calhoun D, Jones D, Textor S et al.; American Heart Association Professional Education Committee (2008) Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 117: 510\u2013526","journal-title":"Circulation"},{"key":"2194_CR4","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","volume":"40","author":"Calhoun","year":"2002","unstructured":"Calhoun D, Nishizaka M, Zaman M et al. (2002) Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 40: 892\u2013896","journal-title":"Hypertension"},{"key":"2194_CR5","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"Chobanian","year":"2003","unstructured":"Chobanian A, Bakris G, Black H et al.; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289: 2560\u20132572","journal-title":"JAMA"},{"key":"2194_CR6","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1001\/archinte.161.9.1207","volume":"161","author":"Coresh","year":"2001","unstructured":"Coresh J, Wei G, McQuillan G et al. (2001) Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey(1988\u20131994). Arch Intern Med 161: 1207\u20131216","journal-title":"Arch Intern Med"},{"key":"2194_CR7","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(08)60834-X","volume":"371","author":"Douma","year":"2008","unstructured":"Douma SKP, Doumas M, Papaefthimiou P et al. (2008) Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet 371: 1921\u20131926","journal-title":"Lancet"},{"key":"2194_CR8","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1097\/00004872-200411000-00026","volume":"22","author":"Eide","year":"2004","unstructured":"Eide I, Torjesen P, Drolsum A et al. (2004) Low-renin status in therapy-resistant hypertension: a clue to efficient treatment. J Hypertens 22: 2217\u20132226","journal-title":"J Hypertens"},{"key":"2194_CR9","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/archinte.168.11.1159","volume":"168","author":"Gaddam","year":"2008","unstructured":"Gaddam K, Nishizaka M, Pratt-Ubunama M et al. (2008) Characterization of resistant hypertension: association between resistant hypertension, aldosterone and persistent intravascular volume expansion. Arch Intern Med 168: 1159\u20131164","journal-title":"Arch Intern Med"},{"key":"2194_CR10","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.amjhyper.2004.11.021","volume":"18","author":"Garg","year":"2005","unstructured":"Garg J, Elliott W, Folker A et al. (2005) Resistant hypertension revisited: a comparison of two university-based cohorts. Am J Hypertens 18: 619\u2013626","journal-title":"Am J Hypertens"},{"key":"2194_CR11","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1378\/chest.07-1170","volume":"132","author":"Gon\u00e7alves","year":"2007","unstructured":"Gon\u00e7alves S, Martinez D, Gus M et al. (2007) Obstructive sleep apnea and resistant hypertension. Chest 132: 1858\u20131862","journal-title":"Chest"},{"key":"2194_CR12","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/01.HYP.0000116223.97436.e5","volume":"43","author":"Goodfriend","year":"2004","unstructured":"Goodfriend T, Calhoun D (2004) Resistant hypertension, obesity, sleep apnea and aldosterone. Theory and therapy. Hypertension 43: 518\u2013524","journal-title":"Hypertension"},{"key":"2194_CR13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1161\/01.HYP.0000052314.95497.78","volume":"41","author":"Hall","year":"2003","unstructured":"Hall J (2003) The kidney, hypertension and obesity. Hypertension 41: 625\u2013633","journal-title":"Hypertension"},{"key":"2194_CR14","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1365-2796.1994.tb00857.x","volume":"236","author":"Isaksson","year":"1994","unstructured":"Isaksson H, Ostergren J (1994) Prognosis in therapy-resistant hypertension. J Intern Med 236: 643\u2013649","journal-title":"J Intern Med"},{"key":"2194_CR15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.7326\/0003-4819-121-4-199408150-00011","volume":"121","author":"Johnson","year":"1994","unstructured":"Johnson A, Nguyen T, Day R (1994) Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med 121: 289\u2013300","journal-title":"Ann Intern Med"},{"key":"2194_CR16","first-page":"673","volume":"141","author":"Leshem","year":"2002","unstructured":"Leshem S, Cohen-Lulav H, Di-Castro N et al. (2002) The frequency and causes of refractory hypertension in primary care practices in the community as compared to those in the distinct advisory clinic for hypertension. Harefuah 141: 673\u2013676 764","journal-title":"Harefuah"},{"key":"2194_CR17","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","volume":"25","author":"Mancia","year":"2007","unstructured":"Mancia G, De Backer G, Dominiczak A et al.; Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology (2007) 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25: 1105\u20131187","journal-title":"J Hypertens"},{"key":"2194_CR18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/08037050310009950","volume":"12","author":"Martell","year":"2003","unstructured":"Martell N, Rodriguez-Cerrillo M, Grobbee D et al. (2003) High prevalence of secondary hypertension and insulin resistance in patients with refractory hypertension. Blood Press 12: 149\u2013154","journal-title":"Blood Press"},{"key":"2194_CR19","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/S0895-7061(97)00318-X","volume":"10","author":"Mezzetti","year":"1997","unstructured":"Mezzetti A, Pierdomenico D, Costantini F et al. (1997) White-coat resistant hypertension. Am J Hypertens 10: 1302\u20131307","journal-title":"Am J Hypertens"},{"key":"2194_CR20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1161\/01.HYP.17.4.565","volume":"17","author":"Modan","year":"1991","unstructured":"Modan M, Almog S, Fuchs Z et al. (1991) Obesity, glucose intolerance, hyperinsulinemia and response to antihypertensive drugs. Hypertension 17: 565\u2013573","journal-title":"Hypertension"},{"key":"2194_CR21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","volume":"42","author":"Mosso","year":"2003","unstructured":"Mosso L, Carvajal C, Gonzales A et al. (2003) Primary aldosteronism and hypertensive disease. Hypertension 42: 161\u2013165","journal-title":"Hypertension"},{"key":"2194_CR22","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.amjhyper.2005.06.013","volume":"18","author":"Muxfeldt","year":"2005","unstructured":"Muxfeldt E, Bloch K, da Rocha Nogueira A, Salles G (2005) True resistant hypertension: is it possible to be recognized in the office? Am J Hypertens 18: 1534\u20131540","journal-title":"Am J Hypertens"},{"key":"2194_CR23","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.amjhyper.2005.01.002","volume":"18","author":"Nishizaka","year":"2005","unstructured":"Nishizaka M, Pratt-Ubama M, Zaman M et al. (2005) Validity of plasma aldosterone-to-renin activity ratio in african american and white subjects with resistant hypertension. Am J Hypertens 18: 805\u2013812","journal-title":"Am J Hypertens"},{"key":"2194_CR24","first-page":"425","volume":"28","author":"Otero","year":"2008","unstructured":"Otero F, Grigorian L, Lado M et al.; Grupo Barbanza (2008) Asociaci\u00f3n entre hipertensi\u00f3n refractoria y riesgo cardiometab\u00f3lico. Estudio HIPERFRE. Nefrologia 28: 425\u2013432","journal-title":"Nefrologia"},{"key":"2194_CR25","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1097\/HJH.0b013e3282a9be30","volume":"25","author":"Pimenta","year":"2007","unstructured":"Pimenta E, Gaddam K, Pratt-Ubunama M et al. (2007) Aldosterone excess and resistance to 24-h blood pressure control. J Hypertens 25: 2131\u20132137","journal-title":"J Hypertens"},{"key":"2194_CR26","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00045415-200008040-00005","volume":"8","author":"Pratt","year":"2000","unstructured":"Pratt J (2000) Low-renin hypertension: More common than we think? Cardiol Rev 8: 202\u2013206","journal-title":"Cardiol Rev"},{"key":"2194_CR27","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1378\/chest.06-1442","volume":"131","author":"Pratt-Ubunama","year":"2007","unstructured":"Pratt-Ubunama M, Nishizaka M, Boedefeld R et al. (2007) Plasma aldosterone is related to severity in obstructive sleep apnea in subjects with resistant hypertension. Chest 131: 453\u2013459","journal-title":"Chest"},{"key":"2194_CR28","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1749-6632.2002.tb04419.x","volume":"970","author":"Torpy","year":"2002","unstructured":"Torpy D, Mullen N, Ilias I, Nieman L (2002) Association of hypertension and hypokalemia with cushing\u2019s syndrome caused by ectopic ACTH secretion: a series of 58 cases. Ann N Y Acad Sci 970: 134\u2013144","journal-title":"Ann N Y Acad Sci"},{"key":"2194_CR29","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1001\/jama.289.18.2363","volume":"289","author":"Wolf-Maier","year":"2003","unstructured":"Wolf-Maier K, Cooper R, Banegas J et al. (2003) Hypertension prevalence and blood pressure levels in 6 european countries, Canada and the United States. JAMA 289: 2363\u20132369","journal-title":"JAMA"},{"key":"2194_CR30","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1001\/archinte.1991.00400090078014","volume":"151","author":"Yakovlevitch","year":"1991","unstructured":"Yakovlevitch M, Black H (1991) Resistant hypertension in a tertiary-care clinic. Arch Intern Med 151: 1786\u20131792","journal-title":"Arch Intern Med"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-008-2194-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-008-2194-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-008-2194-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T00:12:10Z","timestamp":1558570330000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-008-2194-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,30]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["2194"],"URL":"https:\/\/doi.org\/10.1007\/s00108-008-2194-9","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,30]]}}}